Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 03/31/15 | 8-K | Current report filing |
|
34 | |
| 03/20/15 | 8-K | Current report filing |
|
4 | |
| 03/18/15 | D | Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act. |
|
5 | |
| 03/18/15 | 8-K | Current report filing |
|
6 | |
| 03/16/15 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
6 | |
| 03/16/15 | 8-K | Current report filing |
|
5 | |
| 03/12/15 | 8-K | Current report filing |
|
6 | |
| 03/10/15 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
13 | |
| 03/05/15 | 8-K | Current report filing |
|
4 | |
| 02/26/15 | 8-K | Current report filing |
|
5 |
